Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 43

1.

Predicting electrotransfer in ultra-high frequency sub-microsecond square wave electric fields.

Murauskas A, Staigvila G, Girkontaitė I, Zinkevičienė A, Ruzgys P, Šatkauskas S, Novickij J, Novickij V.

Electromagn Biol Med. 2020;39(1):1-8. doi: 10.1080/15368378.2019.1710529. Epub 2019 Dec 29.

PMID:
31884821
2.

Antitumor Response and Immunomodulatory Effects of Sub-Microsecond Irreversible Electroporation and Its Combination with Calcium Electroporation.

Novickij V, Čėsna R, Perminaitė E, Zinkevičienė A, Characiejus D, Novickij J, Šatkauskas S, Ruzgys P, Girkontaitė I.

Cancers (Basel). 2019 Nov 9;11(11). pii: E1763. doi: 10.3390/cancers11111763.

3.

sICAM-1 as potential additional parameter in the discrimination of the Sjögren syndrome and non-autoimmune sicca syndrome: a pilot study.

Zinkevičienė A, Dumalakienė I, Mieliauskaitė D, Vilienė R, Narkevičiūtė I, Girkontaitė I.

Clin Rheumatol. 2019 Oct;38(10):2803-2809. doi: 10.1007/s10067-019-04621-2. Epub 2019 May 31.

PMID:
31152257
4.

Nanosecond duration pulsed electric field together with formic acid triggers caspase-dependent apoptosis in pathogenic yeasts.

Novickij V, Staigvila G, Gudiukaitė R, Zinkevičienė A, Girkontaitė I, Paškevičius A, Švedienė J, Markovskaja S, Novickij J, Lastauskienė E.

Bioelectrochemistry. 2019 Aug;128:148-154. doi: 10.1016/j.bioelechem.2019.04.007. Epub 2019 Apr 9.

PMID:
31003053
5.

Low concentrations of acetic and formic acids enhance the inactivation of Staphylococcus aureus and Pseudomonas aeruginosa with pulsed electric fields.

Novickij V, Lastauskienė E, Staigvila G, Girkontaitė I, Zinkevičienė A, Švedienė J, Paškevičius A, Markovskaja S, Novickij J.

BMC Microbiol. 2019 Apr 3;19(1):73. doi: 10.1186/s12866-019-1447-1.

6.

Inactivation of Escherichia coli Using Nanosecond Electric Fields and Nisin Nanoparticles: A Kinetics Study.

Novickij V, Zinkevičienė A, Stanevičienė R, Gruškienė R, Servienė E, Vepštaitė-Monstavičė I, Krivorotova T, Lastauskienė E, Sereikaitė J, Girkontaitė I, Novickij J.

Front Microbiol. 2018 Dec 12;9:3006. doi: 10.3389/fmicb.2018.03006. eCollection 2018.

7.

Non-invasive nanosecond electroporation for biocontrol of surface infections: an in vivo study.

Novickij V, Zinkevičienė A, Perminaitė E, Čėsna R, Lastauskienė E, Paškevičius A, Švedienė J, Markovskaja S, Novickij J, Girkontaitė I.

Sci Rep. 2018 Sep 28;8(1):14516. doi: 10.1038/s41598-018-32783-7.

8.

Intratumoral Accumulation and Clonal Expansion May Not Be Decisive for Rejection of Allogeneic Tumors by CD8+ T-Lymphocytes.

Juršėnaitė J, Girkontaitė I, Šiaurys A, Mauricas M, Characiejus D.

Anticancer Res. 2018 Aug;38(8):4481-4484. doi: 10.21873/anticanres.12751.

PMID:
30061213
9.

Induction of Different Sensitization Patterns of MRSA to Antibiotics Using Electroporation.

Novickij V, Švedienė J, Paškevičius A, Markovskaja S, Lastauskienė E, Zinkevičienė A, Girkontaitė I, Novickij J.

Molecules. 2018 Jul 20;23(7). pii: E1799. doi: 10.3390/molecules23071799.

10.

Different permeabilization patterns of splenocytes and thymocytes to combination of pulsed electric and magnetic field treatments.

Novickij V, Zinkevičienė A, Valiulis J, Švedienė J, Paškevičius A, Lastauskienė E, Markovskaja S, Novickij J, Girkontaitė I.

Bioelectrochemistry. 2018 Aug;122:183-190. doi: 10.1016/j.bioelechem.2018.04.006. Epub 2018 Apr 10.

PMID:
29656243
11.

Pulsed electric field-assisted sensitization of multidrug-resistant Candida albicans to antifungal drugs.

Novickij V, Švedienė J, Paškevičius A, Markovskaja S, Girkontaitė I, Zinkevičienė A, Lastauskienė E, Novickij J.

Future Microbiol. 2018 Apr;13:535-546. doi: 10.2217/fmb-2017-0245. Epub 2017 Dec 11.

PMID:
29227694
12.

A degradation fragment of type X collagen is a real-time marker for bone growth velocity.

Coghlan RF, Oberdorf JA, Sienko S, Aiona MD, Boston BA, Connelly KJ, Bahney C, LaRouche J, Almubarak SM, Coleman DT, Girkontaite I, von der Mark K, Lunstrum GP, Horton WA.

Sci Transl Med. 2017 Dec 6;9(419). pii: eaan4669. doi: 10.1126/scitranslmed.aan4669.

13.

Increased Numbers of CD4+CD25+ and CD8+CD25+ T-Cells in Peripheral Blood of Patients with Rheumatoid Arthritis with Parvovirus B19 Infection.

Naciute M, Maciunaite G, Mieliauskaite D, Rugiene R, Zinkeviciene A, Mauricas M, Murovska M, Girkontaite I.

In Vivo. 2017 Mar-Apr;31(2):181-185.

14.

Parvovirus B19 infection modulates the levels of cytokines in the plasma of rheumatoid arthritis patients.

Naciute M, Mieliauskaite D, Rugiene R, Maciunaite G, Mauricas M, Murovska M, Girkontaite I.

Cytokine. 2017 Aug;96:41-48. doi: 10.1016/j.cyto.2017.03.002. Epub 2017 Mar 10.

PMID:
28288327
15.

Membrane Permeabilization of Pathogenic Yeast in Alternating Sub-microsecond Electromagnetic Fields in Combination with Conventional Electroporation.

Novickij V, Lastauskienė E, Švedienė J, Grainys A, Staigvila G, Paškevičius A, Girkontaitė I, Zinkevičienė A, Markovskaja S, Novickij J.

J Membr Biol. 2018 Apr;251(2):189-195. doi: 10.1007/s00232-017-9951-4. Epub 2017 Feb 25.

PMID:
28238117
16.

Frequency and significance of parvovirus B19 infection in patients with rheumatoid arthritis.

Naciute M, Mieliauskaite D, Rugiene R, Nikitenkiene R, Jancoriene L, Mauricas M, Nora-Krukle Z, Murovska M, Girkontaite I.

J Gen Virol. 2016 Dec;97(12):3302-3312. doi: 10.1099/jgv.0.000621. Epub 2016 Oct 7.

17.

Activation of Tryptophan and Phenylalanine Catabolism in the Remission Phase of Allergic Contact Dermatitis: A Pilot Study.

Zinkevičienė A, Kainov D, Girkontaitė I, Lastauskienė E, Kvedarienė V, Fu Y, Anders S, Velagapudi V.

Int Arch Allergy Immunol. 2016;170(4):262-268. Epub 2016 Oct 22.

18.

Serum Biomarkers of Allergic Contact Dermatitis: A Pilot Study.

Zinkevičienė A, Kainov D, Lastauskienė E, Kvedarienė V, Bychkov D, Byrne M, Girkontaitė I.

Int Arch Allergy Immunol. 2015;168(3):161-4. doi: 10.1159/000442749. Epub 2016 Jan 21.

19.

Bioluminescence Imaging of Adoptively Transferred Lymphocytes During Allogeneic Tumor Rejection.

Juršėnaitė J, Girkontaitė I, Mauricas M, Eidukevičius R, Šiaurys A, Characiejus D.

Anticancer Res. 2015 Dec;35(12):6573-6.

PMID:
26637871
20.

Melatonin inhibits granulocyte adhesion to ICAM via MT3/QR2 and MT2 receptors.

Černyšiov V, Mauricas M, Girkontaite I.

Int Immunol. 2015 Dec;27(12):599-608. doi: 10.1093/intimm/dxv035. Epub 2015 May 31.

PMID:
26031343
21.

Phenotypic switching of Candida guilliermondii is associated with pseudohyphae formation and antifungal resistance.

Lastauskienė E, Čeputytė J, Girkontaitė I, Zinkevičienė A.

Mycopathologia. 2015 Apr;179(3-4):205-11. doi: 10.1007/s11046-014-9844-3. Epub 2014 Dec 7.

PMID:
25481846
22.

Influence of circadian time and lighting conditions on expression of melatonin receptors 1 and 2 in murine lymphocytes.

Cernysiov V, Bozaite R, Mauricas M, Girkontaite I.

In Vivo. 2014 Sep-Oct;28(5):831-5.

PMID:
25189896
23.

The expression of MTNR3 and nuclear receptors in murine leucocytes.

Cernysiov V, Bozaite R, Mauricas M, Girkontaite I.

In Vivo. 2014 Sep-Oct;28(5):827-30.

PMID:
25189895
24.

Formic acid and acetic acid induce a programmed cell death in pathogenic Candida species.

Lastauskienė E, Zinkevičienė A, Girkontaitė I, Kaunietis A, Kvedarienė V.

Curr Microbiol. 2014 Sep;69(3):303-10. doi: 10.1007/s00284-014-0585-9. Epub 2014 Apr 22.

PMID:
24752490
25.

Specific immunoglobulin E antibodies to saprophytic yeasts in sera of atopic patients allergic to house dust mites.

Zinkeviciene A, Girkontaite I, Citavicius D.

J Investig Allergol Clin Immunol. 2012;22(6):412-8.

26.

Expanded effector memory T-lymphocytes in DBA/2 mice do not inhibit the growth of SL2 tumours.

Jursenaite J, Girkontaite I, Mauricas M, Eidukevicius R, Characiejus D.

In Vivo. 2012 Jul-Aug;26(4):553-7.

PMID:
22773567
27.

Regulation of T-cell-independent and T-cell-dependent antibody production by circadian rhythm and melatonin.

Cernysiov V, Gerasimcik N, Mauricas M, Girkontaite I.

Int Immunol. 2010 Jan;22(1):25-34. doi: 10.1093/intimm/dxp109. Epub 2009 Nov 27.

PMID:
19946015
28.

BOB.1/OBF.1 controls the balance of TH1 and TH2 immune responses.

Brunner C, Sindrilaru A, Girkontaite I, Fischer KD, Sunderkötter C, Wirth T.

EMBO J. 2007 Jul 11;26(13):3191-202. Epub 2007 Jun 14.

29.

Apoptotic cells selectively suppress the Th1 cytokine interferon gamma in stimulated human peripheral blood mononuclear cells and shift the Th1/Th2 balance towards Th2.

Girkontaite I, Urbonaviciute V, Maseda D, Neubert K, Herrmann M, Voll RE.

Autoimmunity. 2007 Jun;40(4):327-30.

PMID:
17516220
30.

Involvement of phosphatidylserine, alphavbeta3, CD14, CD36, and complement C1q in the phagocytosis of primary necrotic lymphocytes by macrophages.

Böttcher A, Gaipl US, Fürnrohr BG, Herrmann M, Girkontaite I, Kalden JR, Voll RE.

Arthritis Rheum. 2006 Mar;54(3):927-38.

31.

The Lsc RhoGEF mediates signaling from thromboxane A2 to actin polymerization and apoptosis in thymocytes.

Harenberg A, Girkontaite I, Giehl K, Fischer KD.

Eur J Immunol. 2005 Jun;35(6):1977-86.

32.

The sphingosine-1-phosphate (S1P) lysophospholipid receptor S1P3 regulates MAdCAM-1+ endothelial cells in splenic marginal sinus organization.

Girkontaite I, Sakk V, Wagner M, Borggrefe T, Tedford K, Chun J, Fischer KD.

J Exp Med. 2004 Dec 6;200(11):1491-501.

33.

Vav1-deficient mice are resistant to MOG-induced experimental autoimmune encephalomyelitis due to impaired antigen priming.

Korn T, Fischer KD, Girkontaite I, Köllner G, Toyka K, Jung S.

J Neuroimmunol. 2003 Jun;139(1-2):17-26.

PMID:
12799016
34.

Lsc is required for marginal zone B cells, regulation of lymphocyte motility and immune responses.

Girkontaite I, Missy K, Sakk V, Harenberg A, Tedford K, Pötzel T, Pfeffer K, Fischer KD.

Nat Immunol. 2001 Sep;2(9):855-62.

PMID:
11526402
35.

Compensation between Vav-1 and Vav-2 in B cell development and antigen receptor signaling.

Tedford K, Nitschke L, Girkontaite I, Charlesworth A, Chan G, Sakk V, Barbacid M, Fischer KD.

Nat Immunol. 2001 Jun;2(6):548-55.

PMID:
11376343
36.

The second messenger binding site of inositol 1,4,5-trisphosphate 3-kinase is centered in the catalytic domain and related to the inositol trisphosphate receptor site.

Bertsch U, Deschermeier C, Fanick W, Girkontaite I, Hillemeier K, Johnen H, Weglöhner W, Emmrich F, Mayr GW.

J Biol Chem. 2000 Jan 21;275(3):1557-64.

37.

Characterization of human type X procollagen and its NC-1 domain expressed as recombinant proteins in HEK293 cells.

Frischholz S, Beier F, Girkontaite I, Wagner K, Pöschl E, Turnay J, Mayer U, von der Mark K.

J Biol Chem. 1998 Feb 20;273(8):4547-55.

38.

Histone-specific Th0 and Th1 clones derived from systemic lupus erythematosus patients induce double-stranded DNA antibody production.

Voll RE, Roth EA, Girkontaite I, Fehr H, Herrmann M, Lorenz HM, Kalden JR.

Arthritis Rheum. 1997 Dec;40(12):2162-71.

PMID:
9416853
39.

Immunosuppressive effects of apoptotic cells.

Voll RE, Herrmann M, Roth EA, Stach C, Kalden JR, Girkontaite I.

Nature. 1997 Nov 27;390(6658):350-1. No abstract available.

PMID:
9389474
40.

Type X collagen expression and hypertrophic differentiation in chondrogenic neoplasias.

Aigner T, Frischholz S, Dertinger S, Beier F, Girkontaité I, von der Mark K.

Histochem Cell Biol. 1997 Jun;107(6):435-40.

PMID:
9243276
41.

Immunolocalization of type X collagen in normal fetal and adult osteoarthritic cartilage with monoclonal antibodies.

Girkontaite I, Frischholz S, Lammi P, Wagner K, Swoboda B, Aigner T, Von der Mark K.

Matrix Biol. 1996 Sep;15(4):231-8.

PMID:
8892223
42.

A rapid ELISA test for detection of human paraproteins.

Girkontaite I, Leckiene M, Trociuk I, Giedraitis V, Mauricas M.

Eur J Clin Chem Clin Biochem. 1996 Apr;34(4):349-53.

PMID:
8704052
43.

Immunochemical study of human immunoglobulin G Fc region.

Girkontaite I, Leckiene M, Mauricas M.

Cancer Biother Radiopharm. 1996 Feb;11(1):87-96.

PMID:
10851523

Supplemental Content

Loading ...
Support Center